Why Revenue Cycle Management Systems Fall Behind—and How to Modernize Them
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
Already a member? Log in here
Palmetto Gives Okay to Medicare Coverage of 5 New Molecular Tests
From - Laboratory Industry Report
Medicare contractors are slowly coming around on covering unproven molecular assays. The most notable new baby steps come from, Palmetto GBA (Columbia, SC), one of Medicare's most important contractors in the form of…
Already a member? Log in here
Reimbursement Trends: 5 More New Molecular Tests Get the Medicare Green Light from Palmetto
...
Already a member? Log in here
Update on Palmetto’s Molecular Dx Testing LCDs
From - Diagnostic Testing & Emerging Technologies
Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for…
Already a member? Log in here
Palmetto Latest Medicare Contractor to Loosen Up on Covering Molecular Dx Testing
...
Already a member? Log in here